PYPD — Polypid Income Statement
0.000.00%
Last trade - 00:00- $26.50m
- $18.28m
Annual income statement for Polypid, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 26.3 | 43.1 | 38.9 | 22.9 | 28 |
| Operating Profit | -26.3 | -43.1 | -38.9 | -22.9 | -28 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -36.9 | -42.6 | -39.4 | -23.8 | -29 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -36.9 | -42.6 | -39.6 | -23.9 | -29 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -36.9 | -42.6 | -39.6 | -23.9 | -29 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -39 | -42.6 | -39.6 | -23.9 | -29 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -62.6 | -67.4 | -60.5 | -16.8 | -4.86 |